Scientific Investigations
Clinical Presentation of Obstructive Sleep Apnea in Patients with Chronic Kidney Disease
http://dx.doi.org/10.5664/jcsm.2028
David D. M. Nicholl, B.H.Sc.1; Sofia B. Ahmed, M.D., M.M.Sc.1,2; Andrea H. S. Loewen, M.D.1,3; Brenda R. Hemmelgarn, M.D., Ph.D.1,2; Darlene Y. Sola, B.Sc.N.1; Jaime M. Beecroft, M.Sc.3; Tanvir C. Turin, M.B.B.S., Ph.D.1; Patrick J. Hanly, M.D.1,3
1Department of Medicine, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada; 2Alberta Kidney Disease Network, Alberta, Canada; 3Sleep Centre, Foothills Medical Centre, University of Calgary, Calgary, Alberta, Canada
Background:
Obstructive sleep apnea (OSA) is an important and common comorbidity in patients with chronic kidney disease (CKD). However, few studies have addressed how OSA presents in this patient population and whether it is clinically apparent.
Objective:
The objectives of this study were to determine if the prevalence and severity of sleep related symptoms distinguished CKD patients with OSA from those without apnea, and whether the clinical presentation of OSA in CKD patients differed from the general OSA population.
Methods:
One hundred nineteen patients were recruited from outpatient nephrology clinics. All patients completed a sleep history questionnaire, the Epworth Sleepiness Scale (daytime sleepiness, ESS > 10), the Pittsburgh Sleep Quality Index (poor sleep quality, PSQI > 5), and underwent overnight cardiopulmonary monitoring for determination of sleep apnea (respiratory disturbance index ≥ 15). CKD patients with OSA (n = 46) were compared to (1) CKD patients without OSA (n = 73) and (2) OSA patients without CKD (n = 230) who were referred to the sleep centre.
Results:
The prevalence of OSA symptoms and PSQI scores did not differ between CKD patients with OSA and CKD patients without apnea. Although the prevalence of daytime sleepiness was higher in CKD patients with OSA compared to CKD patients without apnea (39% vs. 19%, p = 0.033), both daytime sleepiness and other symptoms of sleep apnea were considerably less frequent than in OSA patients without a history of kidney disease.
Conclusions:
The presence of OSA in patients with CKD is unlikely to be clinically apparent. Consequently, objective cardiopulmonary monitoring during sleep is required to reliably identify this comorbidity.
Citation:
Nicholl DDM; Ahmed SB; Loewen AHS; Hemmelgarn BR; Sola DY; Beecroft JM; Turin TC; Hanly PJ. Clinical presentation of obstructive sleep apnea in patients with chronic kidney disease. J Clin Sleep Med 2012;8(4):381-387.
Please login to continue reading the full article
Subscribers to JCSM get full access to current and past issues of the JCSM.
Login to JCSM
Not a subscriber?
Join the American Academy of Sleep Medicine and receive a subscription to JCSM with your membership